Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter and supplier offering a wide range of oncology medicines for international pharmaceutical buyers. Regorafenib Tablets are an important targeted cancer therapy used in the management of certain advanced cancers. Cordium Pharmaceuticals supports pharmaceutical sourcing and international supply from India, including inquiries from the USA, subject to applicable regulatory and import requirements.
Regorafenib Tablets – Overview
Regorafenib is an oral multikinase inhibitor used under specialist medical supervision. The FDA-approved reference product, STIVARGA (regorafenib), is indicated for adults with metastatic colorectal cancer, certain locally advanced or metastatic gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma previously treated with sorafenib.
Regorafenib works by inhibiting multiple kinase pathways involved in tumor growth, blood-vessel formation and tumor progression. Treatment should be prescribed and monitored by a qualified oncology professional based on the patient's condition and previous treatment history.
Regorafenib Tablets Strength and Administration
Regorafenib is commonly supplied as 40 mg tablets. The current U.S. prescribing information for STIVARGA specifies a recommended dose of 160 mg once daily for the first 21 days of a 28-day treatment cycle, taken after a low-fat meal. Dose interruption or reduction may be required depending on tolerability and adverse reactions.
Patients should not change the dose, discontinue treatment or combine regorafenib with other medicines without medical advice.
Uses of Regorafenib
Regorafenib may be prescribed for eligible adult patients with:
Metastatic colorectal cancer (CRC) following specified prior therapies
Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) after prior imatinib and sunitinib
Hepatocellular carcinoma (HCC) previously treated with sorafenib
The appropriate indication depends on the patient's diagnosis, treatment history and physician's assessment.
Safety Information
Regorafenib carries an important warning for hepatotoxicity, including severe and potentially fatal liver injury. Liver function should be monitored before and during treatment. The prescribing information also describes other important risks and adverse reactions, including hand-foot skin reaction, hypertension, fatigue, diarrhea and other clinically significant effects.
This medicine should therefore be used only according to a qualified healthcare professional's prescription and monitoring plan.
Regorafenib Tablets Export from India to USA
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical sourcing and export support from India for international buyers seeking oncology products. For U.S.-bound pharmaceutical shipments, applicable FDA requirements must be satisfied. FDA states that imported prescription drugs are subject to requirements concerning establishment registration, drug listing, applicable FDA approval, labeling and current good manufacturing practices.
Cordium Pharmaceuticals can assist eligible buyers with product availability, commercial quotations, packaging information and export documentation, subject to the applicable regulations and product status.
Why Choose Cordium Pharmaceuticals?
India-based pharmaceutical exporter and supplier
Focus on oncology and specialty pharmaceutical products
International sourcing and export support
Product availability based on current supply
Assistance with commercial documentation and shipping coordination
Professional communication for international pharmaceutical buyers
Frequently Asked Questions
What is Regorafenib used for?
Regorafenib is used for specific advanced cancers, including certain cases of colorectal cancer, GIST and hepatocellular carcinoma.
Is Regorafenib a prescription medicine?
Yes. Regorafenib is a prescription oncology medicine requiring professional medical supervision.
Can Cordium Pharmaceuticals export Regorafenib to the USA?
Cordium Pharmaceuticals can handle international pharmaceutical export inquiries from India, but U.S. shipments must comply with applicable FDA and import requirements.
What strength is commonly available?
Regorafenib is commonly supplied as 40 mg tablets, with the exact product, manufacturer and pack configuration subject to availability.
How can I inquire about Regorafenib Tablets?
International pharmaceutical buyers can contact Cordium Pharmaceuticals for current availability, quotation, product details and export documentation requirements.
Regorafenib Tablets Supplier from India
For reliable pharmaceutical sourcing, Cordium Pharmaceuticals Pvt Ltd offers Regorafenib Tablets from India for eligible international buyers. Contact Cordium Pharmaceuticals to discuss Regorafenib availability, pricing, packaging and export requirements for the USA, subject to applicable regulations.
